This means all dogs, young to old, can be treated early and for as long as needed.†
Galliprant has been in use for over 2 years in the UK and Ireland, helping dogs enjoy more special moments with their owners. As part of the Galliprant In Practice Case Series, Dr Ciaran Jones shares the story of Marble – a seven-year-old Labrador with elbow OA. Watch the one-minute clip below to see how Galliprant got Marble back in action so she could continue enjoying life with her active family.
This means Galliprant fits into everyday life, offering a reassuring long-term option for dogs diagnosed with OA in the prime of the lives.
Name of the veterinary medicinal product: Galliprant 20 mg, 60 mg, and 100 mg tablets for dogs.
* Indication: Galliprant is indicated for the treatment of pain associated with mild to moderate osteoarthritis in dogs. Side effects, precautions, warnings and contraindications: Refer to the product packaging and leaflets for information about side effects, precautions, warnings and contraindications. Storage: Do not store above 30°C. Any half tablets should be stored in the bottle. In order to avoid any accidental ingestion, store tablets out of reach of animals.
†As field studies were limited to 28 days, longer-term treatment should be considered carefully and regular monitoring undertaken by the vet.
Galliprant contains grapiprant. Legal category POM-V (UK) POM (IE).
Further information is available from the Summary of Product Characteristics or datasheet. Advice should always be sought from the medicine prescriber. Information on this veterinary medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu. For further information call Elanco Animal Health on +44(0)1256 353131 or write to: Elanco UK AH limited, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA.
© Elanco or its affiliates. PM-UK-20-1059 August 2021